Profiel
Molly Cameron is currently the Director of Corporate Communications at Marinus Pharmaceuticals, Inc. She previously worked as the Manager of Media & Corporate Communications at Orchard Therapeutics Plc.
Actieve functies van Molly Cameron
| Bedrijven | Functie | Begin |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Public Communications Contact | - |
Eerdere bekende functies van Molly Cameron
| Bedrijven | Functie | Einde |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Public Communications Contact | 01-04-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
